Review





Similar Products

99
NSJ Bioreagents rbp-jk antibody / rbpj
Rbp Jk Antibody / Rbpj, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rbp/RBP-JK+Antibody+%2F+RBPJ/custom%40rq6277%4042789389
Average 99 stars, based on 1 article reviews
rbp-jk antibody / rbpj - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

94
MedChemExpress rbp4 protein rat
Rbp4 Protein Rat, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rbp/RBP4%2C+Human/pm42286842-63-1-9
Average 94 stars, based on 1 article reviews
rbp4 protein rat - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

95
Eclipse Bioinnovations ip sequencing
RNA binding landscape of ECD by eCLIP seq. ( A ) Blot depicting immunoprecipitated (IP) RNA. Protein lysates from UV crosslinked 76NTERT cells expressing vector or FLAG-ECD were subjected to IP using 5 µg each of anti-ECD or FLAG or respective IgG (rabbit-Rb) and IgG (mouse-ms) antibodies. The transcripts pull down by indicated antibodies were end repaired and ligated with a biotin adapter at 3′ end as per the protocol by ECLIPSEBIO antibody IP validation kit. IP samples were run on NuPAGE 4%–12% Bis–Tris protein gels, transferred to nitrocellulose membrane, and visualized using the chemiluminescent nucleic acid detection method. WB depicting IPed ECD protein using anti-FLAG ( B ) and anti-ECD ( C ) antibodies. For WB, IP and 3% of input samples were run on SDS–PAGE gels and transferred to PVDF membrane and probed with ECD antibody. ( D ) The distribution profile of the ECD eCLIP peaks in the human genome from biological duplicates. CDS-coding <t>sequence,</t> UTR-untranslated region . (E ) Enrichment of ECD eCLIP-seq peaks compared to random distribution (expected) to account for the different frequency and size of individual elements. ( F ) The top-ranked motifs discovered de novo from ECD eCLIP-seq peaks by HOMER analysis along with a consensus motif (present in 35% of ECD eCLIP peaks) identified through clustering of top 10 HOMER motifs using STAMP. ( G ) RNA-EMSA with indicated concentrations of purified ECD (lanes 2–7) along with 40 nM of biotinylated RNA probe designed with eCLIP identified the third-ranked purine–pyrimidine-mix motif UCAACGAC (Probe-B). Protein free probe, used as a negative control (lane 1). Competition with 100-fold excess unlabeled probe was performed to determine the binding specificity (lane 7). Samples were processed as mentioned in Fig. . (H, I) FP binding curves depicting the binding affinity of WT ECD to RNA probes designed from eCLIP-identified motifs. ( H ) RNA probe comprising the top-ranked purine-only GAG repeat motif, and ( I ) RNA probe containing the third-ranked purine–pyrimidine-mix UCAACGAC motif.
Ip Sequencing, supplied by Eclipse Bioinnovations, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rbp/RBP-eCLIP/pmc13385996-89-3-14
Average 95 stars, based on 1 article reviews
ip sequencing - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

95
Eclipse Bioinnovations rbp eclip kit
RNA binding landscape of ECD by eCLIP seq. ( A ) Blot depicting immunoprecipitated (IP) RNA. Protein lysates from UV crosslinked 76NTERT cells expressing vector or FLAG-ECD were subjected to IP using 5 µg each of anti-ECD or FLAG or respective IgG (rabbit-Rb) and IgG (mouse-ms) antibodies. The transcripts pull down by indicated antibodies were end repaired and ligated with a biotin adapter at 3′ end as per the protocol by ECLIPSEBIO antibody IP validation kit. IP samples were run on NuPAGE 4%–12% Bis–Tris protein gels, transferred to nitrocellulose membrane, and visualized using the chemiluminescent nucleic acid detection method. WB depicting IPed ECD protein using anti-FLAG ( B ) and anti-ECD ( C ) antibodies. For WB, IP and 3% of input samples were run on SDS–PAGE gels and transferred to PVDF membrane and probed with ECD antibody. ( D ) The distribution profile of the ECD eCLIP peaks in the human genome from biological duplicates. CDS-coding <t>sequence,</t> UTR-untranslated region . (E ) Enrichment of ECD eCLIP-seq peaks compared to random distribution (expected) to account for the different frequency and size of individual elements. ( F ) The top-ranked motifs discovered de novo from ECD eCLIP-seq peaks by HOMER analysis along with a consensus motif (present in 35% of ECD eCLIP peaks) identified through clustering of top 10 HOMER motifs using STAMP. ( G ) RNA-EMSA with indicated concentrations of purified ECD (lanes 2–7) along with 40 nM of biotinylated RNA probe designed with eCLIP identified the third-ranked purine–pyrimidine-mix motif UCAACGAC (Probe-B). Protein free probe, used as a negative control (lane 1). Competition with 100-fold excess unlabeled probe was performed to determine the binding specificity (lane 7). Samples were processed as mentioned in Fig. . (H, I) FP binding curves depicting the binding affinity of WT ECD to RNA probes designed from eCLIP-identified motifs. ( H ) RNA probe comprising the top-ranked purine-only GAG repeat motif, and ( I ) RNA probe containing the third-ranked purine–pyrimidine-mix UCAACGAC motif.
Rbp Eclip Kit, supplied by Eclipse Bioinnovations, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rbp/RBP-eCLIP/pmc13454440-620-5-8
Average 95 stars, based on 1 article reviews
rbp eclip kit - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

95
Eclipse Bioinnovations immunoprecipitation eclip
Intersection of up-regulated genes and <t>eCLIP</t> peaks. (A) Upset plot of genes in which at least one ZFP36L2 eCLIP peak present in both eCLIP duplicate samples from MLTC-1 cells was present in the 3’ UTR and in the set of up-regulated genes from each tissue. (B) Genomic track of 3’ UTR of Serpinh1 , a gene up-regulated in bone marrow. RNA-seq results show higher coverage plot in the KO (red) versus the WT condition (blue). The lower panel shows raw ZFP36L2 IP in green compared with the IgG control in purple. The reproducible eCLIP peaks (across two conditions) are shown as yellow rectangles. One 7-mer ARE is present at the 5’ end of the first eCLIP peak.
Immunoprecipitation Eclip, supplied by Eclipse Bioinnovations, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rbp/RBP-eCLIP/pmc13290092-505-3-8
Average 95 stars, based on 1 article reviews
immunoprecipitation eclip - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

86
Human Protein Atlas hub rbps
Intersection of up-regulated genes and <t>eCLIP</t> peaks. (A) Upset plot of genes in which at least one ZFP36L2 eCLIP peak present in both eCLIP duplicate samples from MLTC-1 cells was present in the 3’ UTR and in the set of up-regulated genes from each tissue. (B) Genomic track of 3’ UTR of Serpinh1 , a gene up-regulated in bone marrow. RNA-seq results show higher coverage plot in the KO (red) versus the WT condition (blue). The lower panel shows raw ZFP36L2 IP in green compared with the IgG control in purple. The reproducible eCLIP peaks (across two conditions) are shown as yellow rectangles. One 7-mer ARE is present at the 5’ end of the first eCLIP peak.
Hub Rbps, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rbp/data+immunohistochemistry/pm42319639-134-9-26
Average 86 stars, based on 1 article reviews
hub rbps - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Abbott Laboratories centrimag rbp
Intersection of up-regulated genes and <t>eCLIP</t> peaks. (A) Upset plot of genes in which at least one ZFP36L2 eCLIP peak present in both eCLIP duplicate samples from MLTC-1 cells was present in the 3’ UTR and in the set of up-regulated genes from each tissue. (B) Genomic track of 3’ UTR of Serpinh1 , a gene up-regulated in bone marrow. RNA-seq results show higher coverage plot in the KO (red) versus the WT condition (blue). The lower panel shows raw ZFP36L2 IP in green compared with the IgG control in purple. The reproducible eCLIP peaks (across two conditions) are shown as yellow rectangles. One 7-mer ARE is present at the 5’ end of the first eCLIP peak.
Centrimag Rbp, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rbp/centrimag+rbp/pm42252272-38-19-21
Average 86 stars, based on 1 article reviews
centrimag rbp - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

91
Santa Cruz Biotechnology rbp jκ
Transcriptomic profiling reveals significant enrichment of lncRNA OTUD6B-AS1 in exosomes derived from LPS-stimulated EECs. (A, B) LPS-exo was treated with RNase A alone or in combination with Triton X-100 for 4 h, and then co-incubated with macrophages. Relative expression levels of iNOS (A) and Arg1 (B) in macrophages. (C) Schematic overview of the RNA sequencing and analysis workflow. (D) Volcano plot showing differentially expressed lncRNAs in LPS-exo compared to Control-exo. (E, F) Gene Ontology (GO) biological process enrichment analysis (E) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis (F) of the differentially expressed lncRNAs. (G) qPCR validation of the 6 upregulated lncRNAs in Control-exo and LPS-exo. (H) LPS-exo was treated with RNase A alone or in combination with Triton X-100 for 4 h, and then co-incubated with macrophages. Relative mRNA expression level of lncRNA OTUD6B-AS1 in macrophages. (I) A proposed competing endogenous RNA (ceRNA) network involving lncRNA OTUD6B-AS1, miR-128, <t>and</t> <t>Notch2.</t> (J) Relative mRNA expression level of lncRNA OTUD6B-AS1 in control and LPS-stimulated EECs. (K, L) RNA fluorescence in situ hybridization (RNA-FISH) showing the subcellular localization of lncRNA OTUD6B-AS1 (red) in EECs (K) and its quantitative cytoplasmic/nuclear distribution (L). Nuclei were stained with DAPI (blue). (M – P) Relative mRNA expression levels of lncRNA OTUD6B-AS1 (M − O) and miR-128 (P) in endometrial tissues from healthy cows and cows with endometritis, as determined by qPCR (O, P) and RNA-FISH (M) with quantification (N). (Q) Western blotting analysis of Notch2, <t>RBP-Jκ,</t> and p-p65 protein levels in endometrial tissues. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
Rbp Jκ, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rbp/Diphtheria+Toxin+A+Antibody/pmc13022686-110-49-50
Average 91 stars, based on 1 article reviews
rbp jκ - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

95
Eclipse Bioinnovations uvp cl 1000 ultraviolet crosslinker
Transcriptomic profiling reveals significant enrichment of lncRNA OTUD6B-AS1 in exosomes derived from LPS-stimulated EECs. (A, B) LPS-exo was treated with RNase A alone or in combination with Triton X-100 for 4 h, and then co-incubated with macrophages. Relative expression levels of iNOS (A) and Arg1 (B) in macrophages. (C) Schematic overview of the RNA sequencing and analysis workflow. (D) Volcano plot showing differentially expressed lncRNAs in LPS-exo compared to Control-exo. (E, F) Gene Ontology (GO) biological process enrichment analysis (E) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis (F) of the differentially expressed lncRNAs. (G) qPCR validation of the 6 upregulated lncRNAs in Control-exo and LPS-exo. (H) LPS-exo was treated with RNase A alone or in combination with Triton X-100 for 4 h, and then co-incubated with macrophages. Relative mRNA expression level of lncRNA OTUD6B-AS1 in macrophages. (I) A proposed competing endogenous RNA (ceRNA) network involving lncRNA OTUD6B-AS1, miR-128, <t>and</t> <t>Notch2.</t> (J) Relative mRNA expression level of lncRNA OTUD6B-AS1 in control and LPS-stimulated EECs. (K, L) RNA fluorescence in situ hybridization (RNA-FISH) showing the subcellular localization of lncRNA OTUD6B-AS1 (red) in EECs (K) and its quantitative cytoplasmic/nuclear distribution (L). Nuclei were stained with DAPI (blue). (M – P) Relative mRNA expression levels of lncRNA OTUD6B-AS1 (M − O) and miR-128 (P) in endometrial tissues from healthy cows and cows with endometritis, as determined by qPCR (O, P) and RNA-FISH (M) with quantification (N). (Q) Western blotting analysis of Notch2, <t>RBP-Jκ,</t> and p-p65 protein levels in endometrial tissues. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
Uvp Cl 1000 Ultraviolet Crosslinker, supplied by Eclipse Bioinnovations, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rbp/RBP-eCLIP/pm42167237-378-21-33
Average 95 stars, based on 1 article reviews
uvp cl 1000 ultraviolet crosslinker - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

Image Search Results


RNA binding landscape of ECD by eCLIP seq. ( A ) Blot depicting immunoprecipitated (IP) RNA. Protein lysates from UV crosslinked 76NTERT cells expressing vector or FLAG-ECD were subjected to IP using 5 µg each of anti-ECD or FLAG or respective IgG (rabbit-Rb) and IgG (mouse-ms) antibodies. The transcripts pull down by indicated antibodies were end repaired and ligated with a biotin adapter at 3′ end as per the protocol by ECLIPSEBIO antibody IP validation kit. IP samples were run on NuPAGE 4%–12% Bis–Tris protein gels, transferred to nitrocellulose membrane, and visualized using the chemiluminescent nucleic acid detection method. WB depicting IPed ECD protein using anti-FLAG ( B ) and anti-ECD ( C ) antibodies. For WB, IP and 3% of input samples were run on SDS–PAGE gels and transferred to PVDF membrane and probed with ECD antibody. ( D ) The distribution profile of the ECD eCLIP peaks in the human genome from biological duplicates. CDS-coding sequence, UTR-untranslated region . (E ) Enrichment of ECD eCLIP-seq peaks compared to random distribution (expected) to account for the different frequency and size of individual elements. ( F ) The top-ranked motifs discovered de novo from ECD eCLIP-seq peaks by HOMER analysis along with a consensus motif (present in 35% of ECD eCLIP peaks) identified through clustering of top 10 HOMER motifs using STAMP. ( G ) RNA-EMSA with indicated concentrations of purified ECD (lanes 2–7) along with 40 nM of biotinylated RNA probe designed with eCLIP identified the third-ranked purine–pyrimidine-mix motif UCAACGAC (Probe-B). Protein free probe, used as a negative control (lane 1). Competition with 100-fold excess unlabeled probe was performed to determine the binding specificity (lane 7). Samples were processed as mentioned in Fig. . (H, I) FP binding curves depicting the binding affinity of WT ECD to RNA probes designed from eCLIP-identified motifs. ( H ) RNA probe comprising the top-ranked purine-only GAG repeat motif, and ( I ) RNA probe containing the third-ranked purine–pyrimidine-mix UCAACGAC motif.

Journal: Nucleic Acids Research

Article Title: A novel RNA-binding activity of ECD contributes to U5 snRNP stability and pre-mRNA splicing

doi: 10.1093/nar/gkag732

Figure Lengend Snippet: RNA binding landscape of ECD by eCLIP seq. ( A ) Blot depicting immunoprecipitated (IP) RNA. Protein lysates from UV crosslinked 76NTERT cells expressing vector or FLAG-ECD were subjected to IP using 5 µg each of anti-ECD or FLAG or respective IgG (rabbit-Rb) and IgG (mouse-ms) antibodies. The transcripts pull down by indicated antibodies were end repaired and ligated with a biotin adapter at 3′ end as per the protocol by ECLIPSEBIO antibody IP validation kit. IP samples were run on NuPAGE 4%–12% Bis–Tris protein gels, transferred to nitrocellulose membrane, and visualized using the chemiluminescent nucleic acid detection method. WB depicting IPed ECD protein using anti-FLAG ( B ) and anti-ECD ( C ) antibodies. For WB, IP and 3% of input samples were run on SDS–PAGE gels and transferred to PVDF membrane and probed with ECD antibody. ( D ) The distribution profile of the ECD eCLIP peaks in the human genome from biological duplicates. CDS-coding sequence, UTR-untranslated region . (E ) Enrichment of ECD eCLIP-seq peaks compared to random distribution (expected) to account for the different frequency and size of individual elements. ( F ) The top-ranked motifs discovered de novo from ECD eCLIP-seq peaks by HOMER analysis along with a consensus motif (present in 35% of ECD eCLIP peaks) identified through clustering of top 10 HOMER motifs using STAMP. ( G ) RNA-EMSA with indicated concentrations of purified ECD (lanes 2–7) along with 40 nM of biotinylated RNA probe designed with eCLIP identified the third-ranked purine–pyrimidine-mix motif UCAACGAC (Probe-B). Protein free probe, used as a negative control (lane 1). Competition with 100-fold excess unlabeled probe was performed to determine the binding specificity (lane 7). Samples were processed as mentioned in Fig. . (H, I) FP binding curves depicting the binding affinity of WT ECD to RNA probes designed from eCLIP-identified motifs. ( H ) RNA probe comprising the top-ranked purine-only GAG repeat motif, and ( I ) RNA probe containing the third-ranked purine–pyrimidine-mix UCAACGAC motif.

Article Snippet: Enhanced cross-linking and IP sequencing (eCLIP seq) and analyses were performed under contract by Eclipse Bioinnovations Inc, San Diego, according to the published single-end seCLIP protocol [ ] with the following modifications.

Techniques: RNA Binding Assay, Immunoprecipitation, Expressing, Plasmid Preparation, Biomarker Discovery, Membrane, SDS Page, Sequencing, Purification, Negative Control, Binding Assay

Intersection of up-regulated genes and eCLIP peaks. (A) Upset plot of genes in which at least one ZFP36L2 eCLIP peak present in both eCLIP duplicate samples from MLTC-1 cells was present in the 3’ UTR and in the set of up-regulated genes from each tissue. (B) Genomic track of 3’ UTR of Serpinh1 , a gene up-regulated in bone marrow. RNA-seq results show higher coverage plot in the KO (red) versus the WT condition (blue). The lower panel shows raw ZFP36L2 IP in green compared with the IgG control in purple. The reproducible eCLIP peaks (across two conditions) are shown as yellow rectangles. One 7-mer ARE is present at the 5’ end of the first eCLIP peak.

Journal: RNA Biology

Article Title: The RNA binding protein ZFP36L2 displays tissue-selective mRNA targeting in mice

doi: 10.1080/15476286.2026.2690792

Figure Lengend Snippet: Intersection of up-regulated genes and eCLIP peaks. (A) Upset plot of genes in which at least one ZFP36L2 eCLIP peak present in both eCLIP duplicate samples from MLTC-1 cells was present in the 3’ UTR and in the set of up-regulated genes from each tissue. (B) Genomic track of 3’ UTR of Serpinh1 , a gene up-regulated in bone marrow. RNA-seq results show higher coverage plot in the KO (red) versus the WT condition (blue). The lower panel shows raw ZFP36L2 IP in green compared with the IgG control in purple. The reproducible eCLIP peaks (across two conditions) are shown as yellow rectangles. One 7-mer ARE is present at the 5’ end of the first eCLIP peak.

Article Snippet: Enhanced Crosslinking and Immunoprecipitation (eCLIP) was performed by EclipseBio BioInnovations Inc (San Diego; https://www.eclipsebio.com/ ) according to [ ] protocol.

Techniques: RNA Sequencing, Control

Transcriptomic profiling reveals significant enrichment of lncRNA OTUD6B-AS1 in exosomes derived from LPS-stimulated EECs. (A, B) LPS-exo was treated with RNase A alone or in combination with Triton X-100 for 4 h, and then co-incubated with macrophages. Relative expression levels of iNOS (A) and Arg1 (B) in macrophages. (C) Schematic overview of the RNA sequencing and analysis workflow. (D) Volcano plot showing differentially expressed lncRNAs in LPS-exo compared to Control-exo. (E, F) Gene Ontology (GO) biological process enrichment analysis (E) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis (F) of the differentially expressed lncRNAs. (G) qPCR validation of the 6 upregulated lncRNAs in Control-exo and LPS-exo. (H) LPS-exo was treated with RNase A alone or in combination with Triton X-100 for 4 h, and then co-incubated with macrophages. Relative mRNA expression level of lncRNA OTUD6B-AS1 in macrophages. (I) A proposed competing endogenous RNA (ceRNA) network involving lncRNA OTUD6B-AS1, miR-128, and Notch2. (J) Relative mRNA expression level of lncRNA OTUD6B-AS1 in control and LPS-stimulated EECs. (K, L) RNA fluorescence in situ hybridization (RNA-FISH) showing the subcellular localization of lncRNA OTUD6B-AS1 (red) in EECs (K) and its quantitative cytoplasmic/nuclear distribution (L). Nuclei were stained with DAPI (blue). (M – P) Relative mRNA expression levels of lncRNA OTUD6B-AS1 (M − O) and miR-128 (P) in endometrial tissues from healthy cows and cows with endometritis, as determined by qPCR (O, P) and RNA-FISH (M) with quantification (N). (Q) Western blotting analysis of Notch2, RBP-Jκ, and p-p65 protein levels in endometrial tissues. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

Journal: Materials Today Bio

Article Title: Exosomal lncRNA OTUD6B-AS1 as a pathogenic nanocarrier promotes inflammatory macrophage polarization in endometritis via a targetable ceRNA circuit

doi: 10.1016/j.mtbio.2026.103027

Figure Lengend Snippet: Transcriptomic profiling reveals significant enrichment of lncRNA OTUD6B-AS1 in exosomes derived from LPS-stimulated EECs. (A, B) LPS-exo was treated with RNase A alone or in combination with Triton X-100 for 4 h, and then co-incubated with macrophages. Relative expression levels of iNOS (A) and Arg1 (B) in macrophages. (C) Schematic overview of the RNA sequencing and analysis workflow. (D) Volcano plot showing differentially expressed lncRNAs in LPS-exo compared to Control-exo. (E, F) Gene Ontology (GO) biological process enrichment analysis (E) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis (F) of the differentially expressed lncRNAs. (G) qPCR validation of the 6 upregulated lncRNAs in Control-exo and LPS-exo. (H) LPS-exo was treated with RNase A alone or in combination with Triton X-100 for 4 h, and then co-incubated with macrophages. Relative mRNA expression level of lncRNA OTUD6B-AS1 in macrophages. (I) A proposed competing endogenous RNA (ceRNA) network involving lncRNA OTUD6B-AS1, miR-128, and Notch2. (J) Relative mRNA expression level of lncRNA OTUD6B-AS1 in control and LPS-stimulated EECs. (K, L) RNA fluorescence in situ hybridization (RNA-FISH) showing the subcellular localization of lncRNA OTUD6B-AS1 (red) in EECs (K) and its quantitative cytoplasmic/nuclear distribution (L). Nuclei were stained with DAPI (blue). (M – P) Relative mRNA expression levels of lncRNA OTUD6B-AS1 (M − O) and miR-128 (P) in endometrial tissues from healthy cows and cows with endometritis, as determined by qPCR (O, P) and RNA-FISH (M) with quantification (N). (Q) Western blotting analysis of Notch2, RBP-Jκ, and p-p65 protein levels in endometrial tissues. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

Article Snippet: The antibodies used include TSG101 (Genuin Biotech, Cat # 51942), CD81 (Santa Cruz Biotechnology, Cat # sc-18877), AKT (abcam, Cat # AB81283), Phospho-AKT (abcam, Cat # AB179463 ), NF-κB p65 (abcam, Cat # AB32536), Phospho-NF-κB p65 (Cell Signaling Technology, Cat # 3033S), Notch2 (Santa Cruz Biotechnology, Cat # sc-51869), RBP-Jκ (Santa Cruz Biotechnology, Cat # sc-271128), and β-actin (Bioss, Cat # bs-0061R).

Techniques: Derivative Assay, Incubation, Expressing, RNA Sequencing, Control, Biomarker Discovery, Fluorescence, In Situ Hybridization, Staining, Western Blot

EECs-derived exosomes induce pro-inflammatory macrophage activation via delivery of lncRNA OTUD6B-AS1. (A) Relative mRNA expression level of lncRNA OTUD6B-AS1 in macrophages treated with Control-exo or LPS-exo. (B, C) RNA-FISH images (B) and quantitative analysis (C) showing lncRNA OTUD6B-AS1 (red) transfer to macrophages after co-culture with Control-exo or LPS-exo. Nuclei were stained with DAPI (blue). (D) Relative mRNA expression level of lncRNA OTUD6B-AS1 in macrophages after transfection with lncRNA OTUD6B-AS1 overexpression plasmids (OE-lncRNA) or control plasmids (OE-NC). ( E – I) Western blotting analysis of Notch2, RBP-Jκ, and p-p65 (E), along with immunofluorescence (IF) quantitative analysis of iNOS (F, G) and Arg1 (H, I) protein levels in macrophages after transfection with OE-lncRNA or OE-NC. (J – N) Western blotting analysis of Notch2, RBP-Jκ, and p-p65 (J), along with IF quantitative analysis of iNOS (K, L) and Arg1 (M, N) protein levels in macrophages after lncRNA OTUD6B-AS1 knockdown (si-lncRNA) or control treatment (si-NC). (O) Relative mRNA expression level of lncRNA OTUD6B-AS1 in exosomes isolated from lncRNA OTUD6B-AS1-knockdown LPS-stimulated EECs (si-lncRNA-LPS-exo) or exosomes from siRNA NC-transfected LPS-stimulated EECs (si-NC-LPS-exo). (P – S) IF quantitative analysis of iNOS (P, Q) and Arg1 (R, S) protein levels in macrophages treated with si-lncRNA-LPS-exo or si-NC-LPS-exo. (T) Relative mRNA expression levels of iNOS and Arg1 in macrophages treated with exosomes isolated from control EECs overexpressing lncRNA OTUD6B-AS1 (OE-lncRNA-Control-exo) or exosomes from control plasmids-transfected EECs (OE-NC-Control-exo). ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

Journal: Materials Today Bio

Article Title: Exosomal lncRNA OTUD6B-AS1 as a pathogenic nanocarrier promotes inflammatory macrophage polarization in endometritis via a targetable ceRNA circuit

doi: 10.1016/j.mtbio.2026.103027

Figure Lengend Snippet: EECs-derived exosomes induce pro-inflammatory macrophage activation via delivery of lncRNA OTUD6B-AS1. (A) Relative mRNA expression level of lncRNA OTUD6B-AS1 in macrophages treated with Control-exo or LPS-exo. (B, C) RNA-FISH images (B) and quantitative analysis (C) showing lncRNA OTUD6B-AS1 (red) transfer to macrophages after co-culture with Control-exo or LPS-exo. Nuclei were stained with DAPI (blue). (D) Relative mRNA expression level of lncRNA OTUD6B-AS1 in macrophages after transfection with lncRNA OTUD6B-AS1 overexpression plasmids (OE-lncRNA) or control plasmids (OE-NC). ( E – I) Western blotting analysis of Notch2, RBP-Jκ, and p-p65 (E), along with immunofluorescence (IF) quantitative analysis of iNOS (F, G) and Arg1 (H, I) protein levels in macrophages after transfection with OE-lncRNA or OE-NC. (J – N) Western blotting analysis of Notch2, RBP-Jκ, and p-p65 (J), along with IF quantitative analysis of iNOS (K, L) and Arg1 (M, N) protein levels in macrophages after lncRNA OTUD6B-AS1 knockdown (si-lncRNA) or control treatment (si-NC). (O) Relative mRNA expression level of lncRNA OTUD6B-AS1 in exosomes isolated from lncRNA OTUD6B-AS1-knockdown LPS-stimulated EECs (si-lncRNA-LPS-exo) or exosomes from siRNA NC-transfected LPS-stimulated EECs (si-NC-LPS-exo). (P – S) IF quantitative analysis of iNOS (P, Q) and Arg1 (R, S) protein levels in macrophages treated with si-lncRNA-LPS-exo or si-NC-LPS-exo. (T) Relative mRNA expression levels of iNOS and Arg1 in macrophages treated with exosomes isolated from control EECs overexpressing lncRNA OTUD6B-AS1 (OE-lncRNA-Control-exo) or exosomes from control plasmids-transfected EECs (OE-NC-Control-exo). ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)

Article Snippet: The antibodies used include TSG101 (Genuin Biotech, Cat # 51942), CD81 (Santa Cruz Biotechnology, Cat # sc-18877), AKT (abcam, Cat # AB81283), Phospho-AKT (abcam, Cat # AB179463 ), NF-κB p65 (abcam, Cat # AB32536), Phospho-NF-κB p65 (Cell Signaling Technology, Cat # 3033S), Notch2 (Santa Cruz Biotechnology, Cat # sc-51869), RBP-Jκ (Santa Cruz Biotechnology, Cat # sc-271128), and β-actin (Bioss, Cat # bs-0061R).

Techniques: Derivative Assay, Activation Assay, Expressing, Control, Co-Culture Assay, Staining, Transfection, Over Expression, Western Blot, Immunofluorescence, Knockdown, Isolation

lncRNA OTUD6B-AS1 acts as a ceRNA by sponging miR-128 to facilitate pro-inflammatory macrophage activation. (A) Relative mRNA expression level of miR-128 in macrophages treated with Control-exo or LPS-exo. (B) Luciferase reporter assay in HEK293T cells co-transfected with wild-type (WT) or mutant (MUT) lncRNA OTUD6B-AS1 reporter plasmids and miR-128 mimic or mimic NC. (C) RNA pull-down detection of the enrichment of miR-128 to lncRNA OTUD6B-AS1. (D) Ago2 RIP assay analysis of the enrichment of lncRNA OTUD6B-AS1 pulled-down from the Ago2 protein. (E) Relative mRNA expression level of miR-128 in macrophages transfected with OE-NC or OE-lncRNA. (F – J) Western blotting analysis of Notch2, RBP-Jκ, and p-p65 (F), along with immunofluorescence (IF) quantitative analysis of iNOS (G, H) and Arg1 (I, J) protein levels in macrophages co-transfected with OE-lncRNA and miR-128 mimic or mimic NC. (K, L) Relative mRNA expression levels of IL-1β (K) and IL-6 (L) in macrophages co-transfected with OE-lncRNA and miR-128 mimic or mimic NC. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.

Journal: Materials Today Bio

Article Title: Exosomal lncRNA OTUD6B-AS1 as a pathogenic nanocarrier promotes inflammatory macrophage polarization in endometritis via a targetable ceRNA circuit

doi: 10.1016/j.mtbio.2026.103027

Figure Lengend Snippet: lncRNA OTUD6B-AS1 acts as a ceRNA by sponging miR-128 to facilitate pro-inflammatory macrophage activation. (A) Relative mRNA expression level of miR-128 in macrophages treated with Control-exo or LPS-exo. (B) Luciferase reporter assay in HEK293T cells co-transfected with wild-type (WT) or mutant (MUT) lncRNA OTUD6B-AS1 reporter plasmids and miR-128 mimic or mimic NC. (C) RNA pull-down detection of the enrichment of miR-128 to lncRNA OTUD6B-AS1. (D) Ago2 RIP assay analysis of the enrichment of lncRNA OTUD6B-AS1 pulled-down from the Ago2 protein. (E) Relative mRNA expression level of miR-128 in macrophages transfected with OE-NC or OE-lncRNA. (F – J) Western blotting analysis of Notch2, RBP-Jκ, and p-p65 (F), along with immunofluorescence (IF) quantitative analysis of iNOS (G, H) and Arg1 (I, J) protein levels in macrophages co-transfected with OE-lncRNA and miR-128 mimic or mimic NC. (K, L) Relative mRNA expression levels of IL-1β (K) and IL-6 (L) in macrophages co-transfected with OE-lncRNA and miR-128 mimic or mimic NC. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.

Article Snippet: The antibodies used include TSG101 (Genuin Biotech, Cat # 51942), CD81 (Santa Cruz Biotechnology, Cat # sc-18877), AKT (abcam, Cat # AB81283), Phospho-AKT (abcam, Cat # AB179463 ), NF-κB p65 (abcam, Cat # AB32536), Phospho-NF-κB p65 (Cell Signaling Technology, Cat # 3033S), Notch2 (Santa Cruz Biotechnology, Cat # sc-51869), RBP-Jκ (Santa Cruz Biotechnology, Cat # sc-271128), and β-actin (Bioss, Cat # bs-0061R).

Techniques: Activation Assay, Expressing, Control, Luciferase, Reporter Assay, Transfection, Mutagenesis, Western Blot, Immunofluorescence

Notch2 mediates the regulatory effect of the lncRNA OTUD6B-AS1/miR-128 axis on macrophage activation. (A) Predictive analysis of miR-128 targets using multiple databases. (B) Western blotting analysis of Notch2 protein levels in macrophages treated with Control-exo or LPS-exo. (C) Western blotting analysis of Notch2 protein levels in macrophages transfected with OE-NC or OE-lncRNA. (D – H) Western blotting analysis of Notch2, RBP-Jκ, and p-p65 (D), along with immunofluorescence (IF) quantitative analysis of iNOS (E, F) and Arg1 (G, H) protein levels in macrophages treated with OE-NC or OE-lncRNA and the Notch2 inhibitor DAPT. (I) Luciferase reporter assay in HEK293T cells co-transfected with WT or MUT Notch2 3′UTR reporter plasmids and miR-128 mimic or mimic NC. (J, K) Relative protein (J) and mRNA (K) expression levels of Notch2 in macrophages transfected with miR-128 mimic or mimic NC. (L – P) Western blotting analysis of Notch2, RBP-Jκ, and p-p65 (L), along with IF quantitative analysis of iNOS (M, N) and Arg1 (O, P) protein levels in macrophages co-treated with miR-128 inhibitor or inhibitor NC and DAPT. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.

Journal: Materials Today Bio

Article Title: Exosomal lncRNA OTUD6B-AS1 as a pathogenic nanocarrier promotes inflammatory macrophage polarization in endometritis via a targetable ceRNA circuit

doi: 10.1016/j.mtbio.2026.103027

Figure Lengend Snippet: Notch2 mediates the regulatory effect of the lncRNA OTUD6B-AS1/miR-128 axis on macrophage activation. (A) Predictive analysis of miR-128 targets using multiple databases. (B) Western blotting analysis of Notch2 protein levels in macrophages treated with Control-exo or LPS-exo. (C) Western blotting analysis of Notch2 protein levels in macrophages transfected with OE-NC or OE-lncRNA. (D – H) Western blotting analysis of Notch2, RBP-Jκ, and p-p65 (D), along with immunofluorescence (IF) quantitative analysis of iNOS (E, F) and Arg1 (G, H) protein levels in macrophages treated with OE-NC or OE-lncRNA and the Notch2 inhibitor DAPT. (I) Luciferase reporter assay in HEK293T cells co-transfected with WT or MUT Notch2 3′UTR reporter plasmids and miR-128 mimic or mimic NC. (J, K) Relative protein (J) and mRNA (K) expression levels of Notch2 in macrophages transfected with miR-128 mimic or mimic NC. (L – P) Western blotting analysis of Notch2, RBP-Jκ, and p-p65 (L), along with IF quantitative analysis of iNOS (M, N) and Arg1 (O, P) protein levels in macrophages co-treated with miR-128 inhibitor or inhibitor NC and DAPT. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.

Article Snippet: The antibodies used include TSG101 (Genuin Biotech, Cat # 51942), CD81 (Santa Cruz Biotechnology, Cat # sc-18877), AKT (abcam, Cat # AB81283), Phospho-AKT (abcam, Cat # AB179463 ), NF-κB p65 (abcam, Cat # AB32536), Phospho-NF-κB p65 (Cell Signaling Technology, Cat # 3033S), Notch2 (Santa Cruz Biotechnology, Cat # sc-51869), RBP-Jκ (Santa Cruz Biotechnology, Cat # sc-271128), and β-actin (Bioss, Cat # bs-0061R).

Techniques: Activation Assay, Western Blot, Control, Transfection, Immunofluorescence, Luciferase, Reporter Assay, Expressing